SCN5A

From Food & Medicine Encyclopedia

SCN5A
Symbol SCN5A
HGNC ID 10586
Alternative symbols
Entrez Gene 6331
OMIM 600163
RefSeq NM_000335
UniProt Q14524
Chromosome 3p21
Locus supplementary data


SCN5A is a gene that encodes the alpha subunit of the cardiac sodium channel, which is crucial for the initiation and propagation of action potentials in cardiac muscle cells. This gene is located on the short arm of chromosome 3 (3p21) and plays a significant role in the electrical activity of the heart.

Function[edit]

The SCN5A gene encodes the alpha subunit of the voltage-gated sodium channel Nav1.5, which is predominantly expressed in cardiac tissue. This channel is responsible for the rapid influx of sodium ions during the initial phase of the cardiac action potential, leading to the depolarization of cardiac myocytes. Proper functioning of Nav1.5 is essential for maintaining normal cardiac rhythm and conduction.

Clinical Significance[edit]

Mutations in the SCN5A gene have been associated with a variety of cardiac arrhythmias and conditions, including:

  • Long QT syndrome (LQT3): A condition characterized by prolonged cardiac repolarization, which can lead to syncope, seizures, or sudden cardiac death.
  • Brugada syndrome: A disorder that causes abnormal electrocardiogram (ECG) findings and an increased risk of sudden cardiac death.
  • Sick sinus syndrome: A group of heart rhythm disorders due to malfunction of the sinus node.
  • Progressive cardiac conduction defect: Also known as Lenègre disease, this condition involves the progressive slowing of cardiac conduction.
  • Dilated cardiomyopathy: A disease of the heart muscle that can lead to heart failure.

Pathophysiology[edit]

Mutations in SCN5A can lead to either gain-of-function or loss-of-function effects on the Nav1.5 channel. Gain-of-function mutations often result in prolonged sodium current, contributing to conditions like Long QT syndrome. Conversely, loss-of-function mutations can reduce sodium current, leading to Brugada syndrome or conduction defects.

Genetic Testing and Diagnosis[edit]

Genetic testing for SCN5A mutations is available and can be used to confirm a diagnosis in individuals with a family history of arrhythmias or sudden cardiac death. Identifying specific mutations can help guide treatment and management strategies.

Treatment[edit]

Management of conditions associated with SCN5A mutations may include lifestyle modifications, pharmacological interventions such as beta-blockers or antiarrhythmic drugs, and in some cases, the implantation of a pacemaker or defibrillator.

Research Directions[edit]

Ongoing research is focused on better understanding the molecular mechanisms by which SCN5A mutations lead to arrhythmias, as well as developing targeted therapies to correct or mitigate these effects.

Also see[edit]



Cardiovascular disease A-Z

Most common cardiac diseases

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A[edit]

B[edit]

C[edit]

D[edit]

E[edit]

H[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I[edit]

K[edit]

L[edit]

M[edit]

N[edit]

O[edit]

P[edit]

R[edit]

S[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T[edit]

V[edit]

W[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.